Full Text

Turn on search term navigation

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Type I Baeyer–Villiger monooxygenases (BVMOs) are flavin-dependent monooxygenases that catalyze the oxidation of ketones to esters or lactones, a reaction otherwise performed in chemical processes by employing hazardous and toxic peracids. Even though various BVMOs are extensively studied for their promising role in industrial biotechnology, there is still a demand for enzymes that are able to retain activity at high saline concentrations. To this aim, and based on comparative in silico analyses, we cloned HtBVMO from the extremely halophilic archaeon Haloterrigena turkmenica DSM 5511. When expressed in standard mesophilic cell factories, proteins adapted to hypersaline environments often behave similarly to intrinsically disordered polypeptides. Nevertheless, we managed to express HtBVMO in Escherichia coli and could purify it as active enzyme. The enzyme was characterized in terms of its salt-dependent activity and resistance to some water–organic-solvent mixtures. Although HtBVMO does not seem suitable for industrial applications, it provides a peculiar example of an alkalophilic and halophilic BVMO characterized by an extremely negative charge. Insights into the behavior and structural properties of such salt-requiring may contribute to more efficient strategies for engineering the tuned stability and solubility of existing BVMOs.

Details

Title
Unique Features of a New Baeyer–Villiger Monooxygenase from a Halophilic Archaeon
Author
Niero, Mattia 1 ; Righetto, Irene 1 ; Beneventi, Elisa 1 ; Patrizia Polverino de Laureto 2   VIAFID ORCID Logo  ; Fraaije, Marco Wilhelmus 3   VIAFID ORCID Logo  ; Filippini, Francesco 1 ; Bergantino, Elisabetta 1   VIAFID ORCID Logo 

 Synthetic Biology and Biotechnology Unit, Department of Biology, University of Padova, viale G. Colombo 3, 35121 Padova, Italy; [email protected] (M.N.); [email protected] (I.R.); [email protected] (E.B.) 
 Department of Pharmacological and Pharmaceutical Sciences, University of Padova, via F. Marzolo 5, 35131 Padova, Italy; [email protected] 
 Molecular Enzymology Group, University of Groningen, Nijenborg 4, 9747AG Groningen, The Netherlands; [email protected] 
First page
128
Publication year
2020
Publication date
2020
Publisher
MDPI AG
e-ISSN
20734344
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2547591070
Copyright
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.